REBECCA SASSAMAN: Open Payments
NPI 1144478009 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 37 payments from 12 companies in 2025. Trend: 2023 $366 · 2024 $333 · 2025 $634
Food & beverage: $539Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $189 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $106 |
| Galderma Laboratories, L.P. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
| ABBVIE INC. | 2 | $44 |
| UCB, Inc. | 1 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Almirall LLC | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: TREMFYA, ILUMYA, NEMLUVIO, SKYRIZI, Bimzelx, Sotyktu, Seysara, COSENTYX.
Industry payments across AL — which companies pay providers there.
